Indenoindolone compounds
US6627650B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2002 |
| Grant date | Sep 30, 2003 |
| Priority date | — |
| Expiry date | Jun 13, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of formula (I): wherein:R represents hydrogen, optionally substituted alkyl or alkenyl,R1 to R8, which may be identical or different, each represents hydrogen, optionally substituted alkyl, hydroxy, acyloxy, optionally substituted amino, carboxy, optionally substituted alkoxy, or alkenyloxy, or one of R1 to R8 forms, with another of R1 to R8 that is adjacent, an alkylenedioxy group,X represents oxygen or NR16 wherein R16 represents hydrogen, alkyl, aryl or arylalkyl,R9 represents hydrogen, aryl, heteroaryl, or optionally substituted, saturated or unsaturated alkyl,an isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base.Medicinal products containing the same which are useful as anti-cancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.